Opus Genetics, Inc. — Form 10-Q
Filed August 6, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
George Magrath (CEO) and Robert Gagnon (CFO) provided standard Sarbanes-Oxley certifications for the Q2 2026 10-Q (quarter ended June 30, 2026), dated August 6, 2026. The officers certified that the financial statements fairly present the company's condition, disclosed no material weaknesses or fraud, and confirmed effective disclosure controls and internal controls over financial reporting. No specific financial data, transactions, or changes are disclosed in these certification exhibits alone.
Why this rating
Boilerplate SOX certifications are standard regulatory filings. No new transactions, guidance changes, or material events disclosed here; purely administrative compliance document.
See more from August 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.